How Is the Botulinum Toxin Market Reshaping Aesthetic and Neuromodulatory Medicine?
The Botulinum Toxin Market is reshaping aesthetic and neuromodulatory medicine by transforming botulinum neurotoxin type A (BoNT‑A) from a niche‑treatment into a mainstream therapeutic and cosmetic tool. Used in both clinical and aesthetic‑settings, BoNT‑A injections temporarily block acetylcholine‑release at neuromuscular junctions, reducing muscle‑activity and glandular‑secretion....
0 Commenti 0 condivisioni 117 Views 0 Anteprima